Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioharvest Sciences (BHST) Net Margin (2023 - 2025)

Bioharvest Sciences has reported Net Margin over the past 3 years, most recently at 22.63% for Q4 2025.

  • For Q4 2025, Net Margin rose 1787.0% year-over-year to 22.63%; the TTM value through Dec 2025 reached 31.83%, up 1941.0%, while the annual FY2025 figure was 31.83%, 1938.0% up from the prior year.
  • Net Margin was 22.63% for Q4 2025 at Bioharvest Sciences, up from 27.72% in the prior quarter.
  • Across five years, Net Margin topped out at 160.07% in Q4 2023 and bottomed at 123.15% in Q1 2024.
  • The 3-year median for Net Margin is 27.72% (2025), against an average of 2.47%.
  • Year-over-year, Net Margin tumbled -20057bps in 2024 and then soared 9340bps in 2025.
  • Over 3 years, Net Margin stood at 160.07% in 2023, then tumbled by -125bps to 40.51% in 2024, then surged by 44bps to 22.63% in 2025.
  • The last three reported values for Net Margin were 22.63% (Q4 2025), 27.72% (Q3 2025), and 47.92% (Q2 2025) per Business Quant data.